The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Smith Brian J since 2006.
The trader's CIK number is 1288288.
At the time of the last reporting, Smith Brian J was the SVP, General Counsel of Hospira Inc. (stock ticker symbol HSP).
Also see all insider trading activities at Hospira Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | HSP | 0 | $0 | 0 | $0 | 195,091 | $8,164,948 |
2014 | HSP | 0 | $0 | 225,700 | $12,915,987 | 225,700 | $8,196,468 |
2012 | HSP | 0 | $0 | 0 | $0 | 9,150 | $0 |
2011 | HSP | 0 | $0 | 0 | $0 | 3,370 | $0 |
2010 | HSP | 0 | $0 | 80,000 | $4,600,000 | 80,000 | $2,120,000 |
2009 | HSP | 10 | $253 | 0 | $0 | 0 | $0 |
2008 | HSP | 4,877 | $188,983 | 0 | $0 | 0 | $0 |
2006 | HSP | 5,000 | $176,500 | 0 | $0 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-09-03 | HSP | Option Ex | 195,091 | 41.85 | 8,164,948 |
2014-11-24 | HSP | Option Ex | 136,100 | 34.92 | 4,753,292 |
2014-11-24 | HSP | Sale | 136,100 | 59.20 | 8,057,392 |
2014-11-21 | HSP | Option Ex | 49,600 | 37.19 | 1,844,376 |
2014-11-21 | HSP | Sale | 49,600 | 59.24 | 2,938,155 |
2014-05-12 | HSP | Option Ex | 40,000 | 39.97 | 1,598,800 |
2014-05-12 | HSP | Sale | 40,000 | 48.01 | 1,920,440 |
2012-03-01 | HSP | Option Ex | 9,150 | .00 | 0 |
2011-02-24 | HSP | Option Ex | 3,370 | .00 | 0 |
2010-04-13 | HSP | Option Ex | 80,000 | 26.50 | 2,120,000 |
2010-04-13 | HSP | Sale | 80,000 | 57.50 | 4,600,000 |
2009-02-23 | HSP | Buy | 10 | 25.39 | 253 |
2008-08-25 | HSP | Buy | 4,877 | 38.75 | 188,983 |
2006-08-14 | HSP | Buy | 5,000 | 35.30 | 176,500 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Smith Brian J (SVP, General Counsel of Hospira Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.